ENRUHE
PF-Atlas › Clinical Trials › NCT04301856

Response to CFTR Modulators in CF Patients Under 18 Years

CFTR Modulators · Not specified

Registry ID
NCT04301856
Phase
Not specified
Status
Unknown
Drug / intervention
CFTR Modulators
Sponsor
Societe Francaise de la Mucoviscidose
Start
2020-01-01

About this trial

CFTR Modulators is evaluated in NCT04301856, a idiopathic pulmonary fibrosis study sponsored by Societe Francaise de la Mucoviscidose. Current status: Unknown.

View NCT04301856 on ClinicalTrials.gov →

Explore related

All CFTR Modulators trialsAll IPF trials

Related trials

CFTR Modulators — NCT04580368Cftr Modulators — NCT04206436CFTR modulators — NCT05581056
Medical disclaimer. This page summarizes public trial data for NCT04301856 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.